Skip to main content

Advertisement

Log in

The Risk Factors and Characteristics of COPD Among Nonsmokers in Korea: An Analysis of KNHANES IV and V

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Purpose

Chronic obstructive pulmonary disease (COPD) is increasing in prevalence and mortality. This study evaluated the prevalence, risk factors, characteristics, and health-related quality of life (HRQoL) of COPD among nonsmokers in Korea.

Methods

This was a population-based cross-sectional study using data obtained from the Fourth and Fifth Korean National Health and Nutrition Examination Survey, which was conducted from 2007 to 2011.

Results

A total of 15,063 participants completely answered the questionnaire and performed the spirometry. Among them, 59.6 % were nonsmokers and 40.4 % were smokers. The prevalence of nonsmoker COPD was 7.1 %. On multivariate analysis, age ≥65 years (OR, 2.93; 95 % CI, 2.44–3.51), male sex (OR, 2.98; 95 % CI, 2.40–3.71), living in rural area (OR, 1.26; 95 % CI, 1.05–1.51), lower body mass index (BMI) (<18.5 kg/m2) (OR, 3.00; 95 % CI, 1.78–5.01), self-reported asthma (OR, 2.72; 95 % CI, 2.05–3.60), and self-reported tuberculosis (OR, 4.73; 95 % CI, 3.63–6.17) showed a significantly higher risk of nonsmoker COPD. Analysis of nonsmoker and smoker COPD revealed that there are more females in nonsmoker COPD patients (73.9 vs. 6.9 %, P < 0.001). Nonsmoker COPD patients presented with impaired mobility, pain/discomfort, and anxiety/depression functions as well as a lower mean EuroQol Five-Dimension Questionnaire utility score, which showed HRQoL.

Conclusions

The burden of nonsmoker COPD was considerable. Older age, male sex, lower BMI, self-reported asthma, and self-reported tuberculosis were risk factors for nonsmoker COPD and there were differences between nonsmoker and smoker COPD in terms of sex, comorbidities, and HRQoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Vestbo J, Hurd SS, Agusti AG et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347–365

    Article  CAS  PubMed  Google Scholar 

  2. Cavailles A, Brinchault-Rabin G, Dixmier A et al (2013) Comorbidities of COPD. Eur Respir Rev 22(130):454–475

    Article  PubMed  Google Scholar 

  3. McGarvey LP, John M, Anderson JA et al (2007) Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 62(5):411–415

    Article  PubMed  PubMed Central  Google Scholar 

  4. Garrido PC, de MiguelDiez J, RejasGutierrez J et al (2006) Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients Results of the EPIDEPOC study. Health Qual Life Outcomes 4:31

    Article  PubMed Central  Google Scholar 

  5. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP et al (2006) Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 130(4):1117–1128

    Article  PubMed  Google Scholar 

  6. Ferrer M, Alonso J, Morera J et al (1997) Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 127(12):1072–1079

    Article  CAS  PubMed  Google Scholar 

  7. DiBonaventura M, Paulose-Ram R, Su J et al (2012) The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. Copd 9(1):46–57

    Article  PubMed  Google Scholar 

  8. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349(9064):1498–1504

    Article  CAS  PubMed  Google Scholar 

  9. Cosio MG, Saetta M, Agusti A (2009) Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 360(23):2445–2454

    Article  CAS  PubMed  Google Scholar 

  10. Perez-Padilla R, Fernandez R, Lopez Varela MV et al (2012) Airflow obstruction in never smokers in five Latin American cities: the PLATINO study. Arch Med Res 43(2):159–165

    Article  PubMed  Google Scholar 

  11. Hagstad S, Ekerljung L, Lindberg A et al (2012) COPD among non-smokers: report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med 106(7):980–988

    Article  PubMed  Google Scholar 

  12. Zhou Y, Wang C, Yao W et al (2009) COPD in Chinese nonsmokers. Eur Respir J 33(3):509–518

    Article  CAS  PubMed  Google Scholar 

  13. Lamprecht B, McBurnie MA, Vollmer WM et al (2011) COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 139(4):752–763

    Article  PubMed  PubMed Central  Google Scholar 

  14. Waked M, Salame J, Khayat G et al (2012) Correlates of COPD and chronic bronchitis in nonsmokers: data from a cross-sectional study. Int J Chron Obstruct Pulmon Dis 7:577–585

    Article  PubMed  PubMed Central  Google Scholar 

  15. Bridevaux PO, Probst-Hensch NM, Schindler C et al (2010) Prevalence of airflow obstruction in smokers and never smokers in Switzerland. Eur Respir J 36(6):1259–1269

    Article  PubMed  Google Scholar 

  16. Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338

    Article  CAS  PubMed  Google Scholar 

  17. Choi JK, Paek D, Lee JO (2005) Normal predictive values of spirometry for Korean population. Tuberc Respir Dis 58(3):230–242

    Article  Google Scholar 

  18. Group TE (1990) EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208

    Article  Google Scholar 

  19. Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33(5):337–343

    Article  CAS  PubMed  Google Scholar 

  20. Lee YK, Nam HS, Chuang LH et al (2009) South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health 12(8):1187–1193

    Article  PubMed  Google Scholar 

  21. Lamprecht B, Schirnhofer L, Kaiser B et al (2008) Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med 102(12):1833–1838

    Article  CAS  PubMed  Google Scholar 

  22. Behrendt CE (2005) Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 128(3):1239–1244

    Article  PubMed  Google Scholar 

  23. Cerveri I, Accordini S, Verlato G et al (2001) Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 18(1):85–92

    Article  CAS  PubMed  Google Scholar 

  24. Kim DS, Kim YS, Jung KS et al (2005) Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 172(7):842–847

    Article  PubMed  Google Scholar 

  25. Caballero A, Torres-Duque CA, Jaramillo C et al (2008) Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest 133(2):343–349

    Article  PubMed  Google Scholar 

  26. Kanervisto M, Vasankari T, Laitinen T et al (2011) Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med 105(8):1140–1146

    Article  PubMed  Google Scholar 

  27. Harik-Khan RI, Fleg JL, Wise RA (2002) Body mass index and the risk of COPD. Chest 121(2):370–376

    Article  PubMed  Google Scholar 

  28. Buist AS, McBurnie MA, Vollmer WM et al (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370(9589):741–750

    Article  PubMed  Google Scholar 

  29. Miravitlles M, Ferrer M, Pont A et al (2005) Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 99(8):985–995

    Article  PubMed  Google Scholar 

  30. Eisner MD (2007) Indoor air, passive smoking, and COPD. Am J Respir Crit Care Med 176(5):426–427

    Article  PubMed  Google Scholar 

  31. Salvi SS, Barnes PJ (2009) Chronic obstructive pulmonary disease in non-smokers. Lancet 374(9691):733–743

    Article  PubMed  Google Scholar 

  32. Nizankowska-Mogilnicka E, Mejza F, Buist AS et al (2007) Prevalence of COPD and tobacco smoking in Malopolska region–results from the BOLD study in Poland. Pol Arch Med Wewn 117(9):402–410

    PubMed  Google Scholar 

  33. Pasipanodya JG, Miller TL, Vecino M et al (2007) Pulmonary impairment after tuberculosis. Chest 131(6):1817–1824

    Article  PubMed  Google Scholar 

  34. Hnizdo E, Singh T, Churchyard G (2000) Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 55(1):32–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Elkington PT, Friedland JS (2006) Matrix metalloproteinases in destructive pulmonary pathology. Thorax 61(3):259–266

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Kim SH, Oh YM, Jo MW (2014) Health-related quality of life in chronic obstructive pulmonary disease patients in Korea. Health Qual Life Outcomes 12:57

    Article  PubMed  PubMed Central  Google Scholar 

  37. Hong JY, Kim SY, Chung KS et al (2015) Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D. Qual Life Res 24(10):2549–2558

    Article  PubMed  Google Scholar 

  38. Roberts SD, Farber MO, Ks Knox et al (2006) FEV1/FVC ratio of 70 % misclassifies patients with obstruction at the extremes of age. Chest 130(1):200–206

    Article  PubMed  Google Scholar 

  39. Hwang YI, Kim CH, Kang HR et al (2009) Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria. J Korean Med Sci 24(4):621–626

    Article  PubMed  PubMed Central  Google Scholar 

  40. Wang Y, Xiao W, Ma DD et al (2013) Predicted lower limit of normal reduces misclassification risk of airflow limitation in asymptomatic elderly never-smokers. Chin Med J 126(18):3486–3492

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Song Yee Kim.

Ethics declarations

Conflict of Interest

None.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, S.H., Hwang, E.D., Lim, J.E. et al. The Risk Factors and Characteristics of COPD Among Nonsmokers in Korea: An Analysis of KNHANES IV and V. Lung 194, 353–361 (2016). https://doi.org/10.1007/s00408-016-9871-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-016-9871-6

Keywords

Navigation